NervGen Pharma Corp. (TSXV:NGEN)
Canada · Delayed Price · Currency is CAD 3.530
+0.260 (7.95%)
Oct 1, 2025, 3:59 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of CAD 258.85 million as of October 1, 2025. Its market cap has increased by 39.18% in one year.
Market Cap
258.85M
Enterprise Value
243.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.53
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 50.07M to 258.85M, an increase of 416.95%. That is a compound annual growth rate of 28.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 239.62M | 8.54% |
| Dec 31, 2024 | 220.77M | 37.18% |
| Dec 29, 2023 | 160.94M | 71.42% |
| Dec 30, 2022 | 93.89M | -24.19% |
| Dec 31, 2021 | 123.84M | 58.14% |
| Dec 31, 2020 | 78.31M | 36.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.41B |
| Green Thumb Industries | 2.72B |
| Trulieve Cannabis | 2.29B |
| dentalcorp Holdings | 2.16B |
| Sienna Senior Living | 1.74B |
| Cronos Group | 1.58B |
| WELL Health Technologies | 1.31B |
| Extendicare | 1.27B |